Correlation Between Tscan Therapeutics and Decisionpoint Systems

Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Decisionpoint Systems at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Decisionpoint Systems into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tscan Therapeutics and Decisionpoint Systems, you can compare the effects of market volatilities on Tscan Therapeutics and Decisionpoint Systems and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Decisionpoint Systems. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Decisionpoint Systems.

Diversification Opportunities for Tscan Therapeutics and Decisionpoint Systems

0.0

Correlation Coefficient

Tscan Therapeutics  Decisionpoint Systems

Pay attention - limited upside

The 3 months correlation between Tscan and Decisionpoint is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Decisionpoint Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Decisionpoint Systems and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Decisionpoint Systems. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Decisionpoint Systems has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Decisionpoint Systems go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and Decisionpoint Systems

If you would invest  51.00  in Decisionpoint Systems on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Decisionpoint Systems or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

Tscan Therapeutics  vs.  Decisionpoint Systems

Tscan Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Decisionpoint Systems

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Decisionpoint Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, Decisionpoint Systems is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Tscan Therapeutics and Decisionpoint Systems

The main advantage of trading using opposite Tscan Therapeutics and Decisionpoint Systems positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Decisionpoint Systems can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decisionpoint Systems will offset losses from the drop in Decisionpoint Systems' long position.

The idea behind Tscan Therapeutics and Decisionpoint Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.